AAMC News - April 14, 2022
Susan Klugman, M.D., comments on prenatal screenings, noting the differences between screenings, which detect potential disease, and tests that provide a diagnosis. Dr. Klugman is professor of pediatrics and of obstetrics & gynecology and women's health at Einstein, and director of reproductive and medical genetics at Montefiore.
Dr. Klugman's ProfileMore coverage on Dr. Klugman
US News & World Report - April 13, 2022
Simon Spivack, M.D., M.P.H., and Jan Vijg, Ph.D., explain their study that suggests some smokers don't develop lung cancer because they have strong natural protection against cancer-causing mutations in lung cells. Dr. Spivack is professor of medicine, of epidemiology & population health, and of genetics at Einstein, and a pulmonologist at Montefiore Health System. Dr. Vijg is professor and chair of genetics, professor of ophthalmology and visual sciences, and the Lola and Saul Kramer Chair in Molecular Genetics at Einstein.
Additional coverage includes UPI, Medical News Today, Genome Web
Dr. Spivak's Profile
BronxNet - April 13, 2022
Edward Chu, M.D., M.M.S., discusses the expertise of recent leadership appointments at the Montefiore Einstein Cancer Center (MECC), along with the center’s research, clinical care, and Bronx community engagement. Dr. Chu is director of MECC, vice president for cancer medicine at Montefiore Medicine, interim chairman of the department of oncology, and the Carol and Roger Einiger Professer of Cancer Medicine at Einstein.
Dr. Chu's ProfileMore coverage on Dr. Chu
Discover Magazine - April 7, 2022
Jonathan Alpert, M.D., Ph.D., discusses a new neurostimulation therapy that uses magnetic pulses to treat depression, and notes that it is among the emerging options that appear to work quickly to heal some patients' brains. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
BronxNet - April 6, 2022
Fourth-year Albert Einstein College of Medicine medical students April Sosa, Emily Bruder, and Daniel Baghdasarian discuss their recent residency matches to Montefiore Health System.
The Scientist - March 25, 2022
Maja Oktay, M.D., Ph.D., talks about cancer metastasis and the tumor microenvironment, which she and colleagues have extensively studied, and how chemotherapy may promote the spread of cancer. Dr. Oktay is professor of pathology and director of the New York Pathology Oncology Group.
Dr. Oktay's ProfileMore coverage on Dr. Oktay
News12 - March 18, 2022
Albert Einstein College of Medicine fourth-year medical students, who spent their clinical years on hospital wards during the COVID-19 pandemic, celebrated Match Day, learning where they will start the next phase of their medical education as resident physicians. Thirty will join an Einstein-affiliated residency program, including 28 at Montefiore.
Medical News Today - March 11, 2022
Michael Lipton, M.D., Ph.D., notes the limitations of a small study linking nerve damage in long COVID to immune dysfunction, but says the underlying mechanism causing neuropathy is likely related to inflammation or autoimmunity. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
Dr. Lipton's ProfileMore coverage on Dr. Lipton
UPI - March 11, 2022
Priya Nori, M.D., says the COVID-19 pandemic can be declared over only when there are no new variants on the horizon, a high level of population immunity, and no outbreak hotspots. Dr. Nori is associate professor of medicine and of orthopaedic surgery at Einstein and medical director of the antimicrobial stewardship program at Montefiore.
Dr. Nori's ProfileMore coverage on Dr. Nori
Nature - March 10, 2022
Betsy Herold, M.D., comments on a study that found low levels of antibodies to the SARS-CoV-2 virus in children who have been infected, suggesting they have a weaker adaptive immune response than adults. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and the Children's Hospital at Montefiore, and the Harold and Muriel Block Chair in Pediatrics at Einstein.
Additional coverage includes MedPageToday
Dr. Herold's ProfileMore coverage on Dr. Herold
Genetic Engineering & Biotechnology News - March 8, 2022
Evripidis Gavathiotis, Ph.D., comments on his discovery of a highly promising strategy for overcoming a key cause of cancer deaths: the ability of cancer cells to thrive in the face of chemotherapy drugs designed to destroy them. Dr. Gavathiotis is professor of biochemistry and of medicine at Einstein and co-leader of the Cancer Therapeutics Program at the NCI-designated Albert Einstein Cancer Center.
Dr. Gavathiotis's ProfileMore coverage on Dr. Gavathiotis
UPI - March 7, 2022
Amit Verma, M.B.B.S., discusses his study that found first responders who were at the World Trade Center on 9/11 have two to three times the number of blood cell mutations that are linked to leukemia, heart attacks, diabetes, and asthma compared to first responders who were not at the site. Dr. Verma is associate director for translational science at the NCI-designated Albert Einstein Cancer Center, professor of medicine and of developmental and molecular biology at Einstein, and director of hemato-oncology at Montefiore.
Additional coverage includes MedPage Today, Boston Herald, ASCO Post
Dr. Verma's ProfileMore coverage on Dr. Verma
The New York Times - February 25, 2022
Hina Talib, M.D., suggests parents look for signs that their children are anxious about the war in Ukraine and offers advice on how to discuss the topic with them. Dr. Talib is associate professor of pediatrics and of obstetrics & gynecology and women's health at Einstein and a pediatrician at the Children's Hospital at Montefiore.
Dr. Talib's ProfileMore coverage on Dr. Talib
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski